Previous studies have reported lower serum PON1 activity in atherosclerotic diseases, myocardial infarction, hypercholesterolemia and diabetes mellitus.22 Yildiz et al.21 also demonstrated lower PON1 activity in CSF subjects than in controls. Here, PON1 is linked to myocardial infarction.